This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duverne, C Articles by Carbon, C Search for Related Content PubMed PubMed Citation Articles by Duverne, C Articles by Carbon, C

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 November; 36(11): 2462-2467

Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system.

C Duverne, A Bouten, A Deslandes, J F Westphal, J H Trouvin, R Farinotti and C Carbon

Département de Pharmacie Clinique et des Biomatériaux, Hospital Bichat, Paris, France.

ABSTRACT

We studied the action of nifedipine on the bioavailability of cefixime, a molecule absorbed via the gut wall dipeptide carrier system in the rat, and on the bioavailability of D-xylose, which is absorbed via a pH (and Na(+)-)-dependent transporter. Each compound was administered alone or in combination with 20 mg of nifedipine to eight healthy male volunteers. Nifedipine significantly increased the absorption rate of cefixime (20.7 +/- 4.3 versus 16 +/- 3.5 mg/h in the absence of nifedipine). The absolute bioavailability of cefixime alone was 31% +/- 6% compared with 53% +/- 1% (P < 0.01) in the presence of nifedipine. The observed peak concentrations in serum were significantly different (2.5 +/- 0.3 mg/liter without nifedipine and 3.7 +/- 1.1 mg/liter with nifedipine; P < 0.02). In contrast, nifedipine induced no significant differences in the pharmacokinetic profile of xylose following oral administration. We conclude that (i) cefixime is absorbed in humans by an apparently active process which can be enhanced by a calcium channel blocker, in this case, nifedipine; and (ii) nifedipine does not modify the activity of the pentose transporter.

---

Antimicrob Agents Chemother. 1992 November; 36(11): 2462-2467

This article has been cited by other articles:

• Wenzel, U., Kuntz, S., Diestel, S., Daniel, H. (2002). PEPT1-Mediated Cefixime Uptake into Human Intestinal Epithelial Cells Is Increased by Ca2+ Channel Blockers. Antimicrob. Agents Chemother. 46: 1375-1380 [Abstract] [Full Text]  
• Berlioz, F., Lepére-Prevot, B., Julien, S., Tsocas, A., Carbon, C., Rozé, C., Farinotti, R. (2000). Chronic Nifedipine Dosing Enhances Cephalexin Bioavailability and Intestinal Absorption in Conscious Rats. Drug Metab. Dispos. 28: 1267-1269 [Abstract] [Full Text]  
• Berlioz, F., Julien, S., Tsocas, A., Chariot, J., Carbon, C., Farinotti, R., Rozé, C. (1999). Neural Modulation of Cephalexin Intestinal Absorption Through the Di- and Tripeptide Brush Border Transporter of Rat Jejunum In Vivo. J. Pharmacol. Exp. Ther. 288: 1037-1044 [Abstract] [Full Text]  
• Harcouët, L., Lebrec, D., Rozé, C., Carbon, C., Farinotti, R. (1997). Increased Intestinal Absorption of Cefixime by Nifedipine in the Rat Intestinal Perfusion Model: Evidence for a Neural Regulation. J. Pharmacol. Exp. Ther. 281: 738-745 [Abstract] [Full Text]